Articles
Volume 10 Supplement 2
Familial Aspects of Cancer 2011 Research and Practice
Meeting abstracts
Familial Aspects of Cancer 2011 Research and Practice: A combined meeting of kConFab, Australian Breast Cancer Family Study, Australian Colorectal Cancer Family Study, Australian Ovarian Cancer Study, Family Cancer Clinics of Australia and New Zealand and kConFab
Kingscliff, Australia
23-26 August 2011
Edited by Rodney Scott
|
Meeting abstract
Clinical management of women in BRCAX families: issues and controversies G Mitchell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A1 (12 April 2012) |
|
Meeting abstract
Polyposis syndromes– what to do when genotyping seems not informative F Macrae Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A2 (12 April 2012) |
|
Meeting abstract
Inherited and DM Thomas, ML Ballinger, International Sarcoma Kindred Study Consortium Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A3 (12 April 2012) |
|
Meeting abstract
A McEwen Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A4 (12 April 2012) |
|
Meeting abstract
B Meiser, MA Price, PN Butow, J Karatas, M Charles, KA Phillips, kConFab Psychosocial and Clinical Follow-Up groups, kConFab investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A5 (12 April 2012) |
|
Meeting abstract
N Hallowell, L Heiniger, B Baylock, M Price, P Butow, kConFab Psychosocial Group, kConFab Investigators Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A6 (12 April 2012) |
|
Meeting abstract
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes AJ Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A7 (12 April 2012) |
|
Meeting abstract
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour E Algar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A8 (12 April 2012) |
|
Meeting abstract
An update of clinical issues from InSIGHT 2011 L Lipton Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A9 (12 April 2012) |
|
Meeting abstract
Selecting women for breast cancer chemoprevention and what agents should be used J Cuzick Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A10 (12 April 2012) |
|
Meeting abstract
KA Phillips, RL Milne, MA Rookus, D Goldgar, M Friedlander, SA McLachlan, S Buys, AC Antoniou, K Birch, MB Terry, DF Easton, P Weideman, M Daly, N Andrieu, EM John, MJ Hooning, IL Andrulis, T Caldes, H Olsson, JL Hopper Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A11 (12 April 2012) |
|
Meeting abstract
Bowel cancer chemoprevention - ready for the clinic? J Burn Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A12 (12 April 2012) |
|
Meeting abstract
Risk-reducing surgery for breast and ovarian cancer risks - where are we now? N Hallowell, B Baylock, L Heiniger, M Price, P Butow Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A13 (12 April 2012) |
|
Meeting abstract
H Shipman, A Clarke Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A14 (12 April 2012) |
|
Meeting abstract
MA Young, S Wake, K Alsop, D Bowtell, G Mitchell, The Australian Ovarian Cancer Study Group, L Plunkett, A Crook, M Gleeson, N Hallowell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A15 (12 April 2012) |
|
Meeting abstract
Peer live supervision in the familial cancer setting M Kentwell, A Sexton, L Hodgkin, Y Bylstra, M Bogwitz, K Mann, J Taylor, M Sahhar, F Pearce, I Winship, GJ Lindeman Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A16 (12 April 2012) |
|
Meeting abstract
S Buscombe Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A17 (12 April 2012) |
|
Meeting abstract
L Schofield, F Grieu, J Goldblatt, B Amanuel, B Iacopetta Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A18 (12 April 2012) |
|
Meeting abstract
KS Boparai, E Dekker, CJM van Noesel Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A19 (12 April 2012) |
|
Meeting abstract
Serrated polyposis syndrome and colonoscopic surveillance: who is it safe to follow? S Parry, S Woodall, G Willdridge, MD Walsh, DD Buchanan, C Rosty, JP Young Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A20 (12 April 2012) |
|
Meeting abstract
A study of cancer risks in relatives of patients with serrated polyposis AK Win, RJ Walters, DD Buchanan, MA Jenkins, K Sweet, DM McKeone, MD Walsh, M Clendenning, SA Pearson, E Pavluk, B Nagler, JL Hopper, Genetics of Serrated Neoplasia investigators, N Walker, C Rosty, S Parry, JP Young Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A21 (12 April 2012) |
|
Meeting abstract
Mismatch repair gene mutations and cancer risks: an update AK Win, JL Hopper, MA Jenkins, Australasian Colorectal Cancer Family Study and the Colon Cancer Family Registry Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A22 (12 April 2012) |
|
Meeting abstract
DD Buchanan, AK Win, R Walters, MD Walsh, M Clendenning, B Nagler, E Pavluk, SA Pearson, C Rosty, J Maskiell, JL Hopper, MA Jenkins, JP Young Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A23 (12 April 2012) |
|
Meeting abstract
Targeting oncogenes in advanced melanoma GA McArthur Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A24 (12 April 2012) |
|
Meeting abstract
Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics SR Oakes, F Vaillant, E Lim, L Lee, K Breslin, F Feleppa, S Deb, ME Ritchie, E Takano, T Ward, SB Fox, D Generali, GK Smyth, A Strasser, DCS Huang, JE Visvader, GJ Lindeman Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A25 (12 April 2012) |
|
Meeting abstract
Inherited and David M Thomas, Mandy L Ballinger, International Sarcoma Kindred Study Consortium Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A26 (12 April 2012) |
|
Meeting abstract
KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, SA Gayther, SJ Chanock, AC Antoniou, PDP Pharoah Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A27 (12 April 2012) |
|
Meeting abstract
S Sawyer, J McKinley, G Mitchell, G Chenevix-Trench, M Harris, G Lindeman, PA James Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A28 (12 April 2012) |
|
Meeting abstract
A breast cancer prediction model incorporating familial and personal risk factors Jack Cuzick Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A29 (12 April 2012) |
|
Meeting abstract
A genetic journey through cancer: from rarity and family to aspirin and nanowires J Burn Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A30 (12 April 2012) |
|
Meeting abstract
B Thompson, D Goldgar, C Paterson, M Clendenning, R Walters, S Arnold, M Parsons, M Walsh, J Hopper, M Jenkins, M Greenblatt, Colon Cancer Family Registry, D Buchanan, J Young, S Tavtigian, A Spurdle Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A31 (12 April 2012) |
|
Meeting abstract
Bente A Talseth-Palmer, Juul T Wijnen, Ingvild S Brenne, Shantie Jagmohan-Changur, Katie A Ashton, Carli M Tops, Tiffany-Jane Evans, Mary McPhillips, Claire Groombridge, Janina Suchy, Grzegorz Kurzawski, The Dutch Cancer Genetics Group, Allan Spigelman, Pål Møller, Hans M Morreau, Tom Van Wezel, Jan Lubinski, Hans FA Vasen, Rodney J Scott Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A32 (12 April 2012) |
|
Meeting abstract
Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers JG Dowty, AK Win, D Buchanan, RJ Macinnis, N Lindor, SN Thibodeau, G Casey, S Gallinger, L LeMarchand, P Newcomb, R Haile, J Goldblatt, S Parry, FA Macrae, JL Hopper, MA Jenkins, Colon Cancer Family Registry Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A33 (12 April 2012) |
|
Meeting abstract
OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers H Gabra Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A34 (12 April 2012) |
|
Meeting abstract
Reclassifying ovarian cancer: origins, subtypes and resistance to therapy DDL Bowtell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A35 (12 April 2012) |
|
Meeting abstract
Georgia Chenevix-Trench, Yi Lu, Sharon Johnatty, Eric Gamazon, Jonathan Beesley, Xiaoqing Chen, Bo Gao, Paul Harnett, R Stephanie Huang, Evelyn Despierre, Florian Heitz, Estrid Hogdall, Claus Hogdall, Robert Brown, Kirsten Moyisch, Peter Fasching, Ellen Goode, Amanda Russell, Michelle Henderson, Michelle Haber, Eileen Dolan, Stuart Macgregor, Anna deFazio, Ovarian Cancer Association Consortium (OCAC) Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A36 (12 April 2012) |
|
Meeting abstract
Monica Ganzinelli, Enilze Ribeiro, Ramona Bertoni, Letizia Bazzola, Daniele Andreis, Alberto Bottini, Roberto Giardini, Camillo Rossi, Giovanna Damia, Daniele Generali Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A37 (12 April 2012) |
|
Meeting abstract
Design considerations for massively parallel sequencing studies of common familial cancers BJ Feng, SV Tavtigian, MC Southey, DE Goldgar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A38 (12 April 2012) |
|
Meeting abstract
Whole genome sequencing in the study of disease and application in personalised medicine A Kumarasuriyar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A39 (12 April 2012) |
|
Meeting abstract
Identification of new breast cancer predisposition genes via whole exome sequencing MC Southey, DJ Park, F Lesueur, F Odefrey, T Nguyen-Dumont, F Hammet, SL Neuhausen, EM John, IL Andrulis, G Chenevix-Trench, L Baglietto, F Le Calvez-Kelm, M Pertesi, A Lonie, B Pope, O Sinilnikova, H Tsimiklis, MCCS, BCFR, kConFab, GG Giles, JL Hopper, SV Tavtigian, DE Goldgar Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A40 (12 April 2012) |
|
Meeting abstract
Identification of breast cancer susceptibility genes using whole exome sequencing E Thompson, M Doyle, J Ellul, J Li, I Campbell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A41 (12 April 2012) |
|
Meeting abstract
M Kentwell, M Bogwitz, L Donoghue, T McArdle Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A42 (12 April 2012) |
|
Meeting abstract
E Lynch, RE Duncan, F Macrae, M Delatycki Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A43 (12 April 2012) |
|
Meeting abstract
Clinical practice improvement in the genetics clinic S Greening Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A44 (12 April 2012) |
|
Meeting abstract
Is the whole greater than the sum of its parts? L Andrews, J Duffy Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A45 (12 April 2012) |
|
Meeting abstract
From GWAS to genome sequencing: complementary approaches to identify melanoma predisposition genes S MacGregor, KM Brown, M Stark, M Gartside, S Woods, V Bonazzi, L Aoude, K Dutton-Regester, S Tyagi, J Liu, DL Duffy, J Palmer, A Cust, H Schmid, J Symmons, E Holland, C Agha-Hamilton, K Holohan, D Youngkin, E Gillanders, MA Jenkins, J Kelly, DC Whiteman, R Kefford, G Giles, B Armstrong, J Aitken, J Hopper, G Montgomery, C Schmidt, JM Trent, NG Martin, GJ Mann, NK Hayward et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A46 (12 April 2012) |
|
Meeting abstract
A genome-wide association study to identify genetic markers associated with endometrial cancer grade T O’Mara, D Duffy, DJ Thompson, S Ahmed, K Ferguson, CS Healey, ANECS, G Montgomery, M Shah, J Morrison, PP Pharoah, AM Dunning, PM Webb, DF Easton, AB Spurdle Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A47 (12 April 2012) |
|
Meeting abstract
‘Next-generation’ genome wide association studies J Hopper, E Makalic, D Schmidt, M Bui, J Stone, M Kapuscinski, D Park, M Jenkins, M Southey Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A48 (12 April 2012) |
|
Meeting abstract
An audit of treatment focussed BRCA1/2 mutation testing at an integrated Familial Cancer Clinic A Lewis, L Cicciarelli, D Pandey, CM Lovett, R Driessen, S Sawyer, MA Young, G Mitchell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A49 (12 April 2012) |
|
Meeting abstract
Audit of adherence to GI screening recommendations for Lynch Syndrome Patients Lucinda Hossack, Omid Zarghom, Gillian Mitchell, Mary Shanahan, Craig Lynch, Alexander Heriot, Alex Boussioutas Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A50 (12 April 2012) |
|
Meeting abstract
Observation of the cancer patient journey: a learning curve for Genetic Counsellors JA Taylor, KJ Mann Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A51 (12 April 2012) |
|
Meeting abstract
C Smyth, C Holding, C Hunt, S O’Connell, E Johnson, N Gelfand, M Harris Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A52 (12 April 2012) |
|
Meeting abstract
Making a good model better - evaluation of the NSW Combined Family Cancer Clinic meetings Lynne Purser, Kathy Tucker, Kristine Barlow-Stewart, Kate Dunlop Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A53 (12 April 2012) |
|
Meeting abstract
What are the unmet support needs of women with a known BRCA1/2 mutation? V White, A Farrelly, B Meiser, M Jefford, M Young, I Winship, S Ieropoli, J Koehler Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A54 (12 April 2012) |
|
Meeting abstract
East meets west: cross-cultural ethnic focussed genetic-counselling Risha Zia, Lesley Andrews Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A55 (12 April 2012) |
|
Meeting abstract
Y Bylstra, M Kentwell, GJ Lindeman, I Winship, L Hodgkin Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A56 (12 April 2012) |
|
Meeting abstract
Case study: positive outcomes from a negative R Williams, K Tucker Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A57 (12 April 2012) |
|
Meeting abstract
Early experience in a breast and ovarian cancer risk management clinic in Malaysia NA Taib, YL Woo, SY Yoon, R Kartini, MK Thong, CH Yip, SH Teo Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A58 (12 April 2012) |
|
Meeting abstract
RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers S Deb, X Huiling, H Thorne, A Willems-Jones, KconFab Investigators, D Clouston, D Bolton, R Ramsay, SB Fox Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A59 (12 April 2012) |
|
Meeting abstract
NK Poplawski, L Rawlings, J Seymour, C Vakulin, A Tirimacco, DE Benn, AJ Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A60 (12 April 2012) |
|
Meeting abstract
K Mahendran, M Ballinger, J Kirk, D Thomas, M Tattersall Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A61 (12 April 2012) |
|
Meeting abstract
Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice AC Blackburn, M Rooke, Y Li, JE Dahlstrom, PG Board Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A62 (12 April 2012) |
|
Meeting abstract
Referral of Queensland women with endometrial cancer to genetic services YY Tan, J McGaughran, A Obermair, A Spurdle Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A63 (12 April 2012) |
|
Meeting abstract
Familial platelet disorders with a predisposition to acute myelogenous leukaemia: a RUNX1 update J Rossini, B Mercorella, S Townshend, C Vakulin, L Rawlings, X Li, C Hahn, H Scott Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A64 (12 April 2012) |
|
Meeting abstract
J Duffy, S Greening, B Creighton Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A65 (12 April 2012) |
|
Meeting abstract
R MacInnis, G Dite, A Bickerstaffe, J Dowty, K Aujard, C Apicella, K Phillips, P Weideman, J Hopper Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A66 (12 April 2012) |
|
Meeting abstract
J Gale Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A67 (12 April 2012) |
|
Meeting abstract
Searching for BRCA3 by exome sequencing I Makunin, M Stark, M Gartside, kConFab, G Chenevix-Trench Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A68 (12 April 2012) |
|
Meeting abstract
Bowel cancer in a 17 year old: what could be the reason? M Bowman, E Edwards, A Goodwin, J Kirk Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A69 (12 April 2012) |
|
Meeting abstract
Role of oncology/genetics nurse in management of individuals with hereditary diffuse gastric cancer M Shanahan, MA Young, G Mitchell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A70 (12 April 2012) |
|
Meeting abstract
JJ Li, S Healey, K Phillips, I Makunin, N Wayte, I Schrader, D Worthley, N Lindor, D Huntsman, D Goldgar, G Suthers, G Chenevix-Trench Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A71 (12 April 2012) |
|
Meeting abstract
The InSiGHT approach to classification of mismatch repair gene variants JP Plazzer Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A72 (12 April 2012) |
|
Meeting abstract
A Lewis, P James Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A73 (12 April 2012) |
|
Meeting abstract
Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome S Parry, AK Win, B Parry, M Kalady, FA Macrae, NM Lindor, RW Haile, PA Newcomb, L Le Marchand, S Gallinger, JL Hopper, MA Jenkins, Colon Cancer Family Registry Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A74 (12 April 2012) |
|
Meeting abstract
M Parsons, B Thompson, D Goldgar, J Hopper, M Jenkins, Colon Cancer Family Registry, D Buchanan, J Young, A Spurdle Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A75 (12 April 2012) |
|
Meeting abstract
E Edwards, M Bowman, M Walsh, J Kirk Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A76 (12 April 2012) |
|
Meeting abstract
State-wide population screening for Lynch syndrome? Improved ascertainment of at risk families J Goldblatt, B Iacopetta, B Amanuel, L Schofield Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A77 (12 April 2012) |
|
Meeting abstract
L Lipton, M Kentwell, M Li, D Williams, M Christie, A Landgren, C Dow, I Jones, S McLaughlin, M Delatycki, F Macrae, E Lynch Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A78 (12 April 2012) |
|
Meeting abstract
Bone density loss after risk reducing salpingo-oophorectomy L Andrews, B Zielony, C White Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A79 (12 April 2012) |
|
Meeting abstract
Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study J Hung, S Fereday, P Harnett, D Giles, B Gao, N Traficante, AOCS Study Group, G Chenevix-Trench, A Green, P Webb, D Bowtell, A DeFazio Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A80 (12 April 2012) |
|
Meeting abstract
Integrated genomic analysis and functional characterisation of novel oncogenes in ovarian cancer SJ Davis, KJ Simpson, IG Campbell, KL Gorringe Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A81 (12 April 2012) |
|
Meeting abstract
Pathological diagnosis of ovarian cancer Hilda High, Michael Friedlander Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A82 (12 April 2012) |
|
Meeting abstract
Benign serous ovarian tumour: a redefining moment? Sally Hunter, Kylie Gorringe, Michael Anglesio, AOCS, Raghwa Sharma, Blake Gilks, Anna deFazio, David Huntsman, Ian Campbell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A83 (12 April 2012) |
|
Meeting abstract
ER Thompson, SE Boyle, J Johnson, GL Ryland, S Sawyer, DY Choong, kConFab, G Chenevix-Trench, AH Trainer, GJ Lindeman, G Mitchell, PA James, IG Campbell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A84 (12 April 2012) |
|
Meeting abstract
AN Hosein, S Cocciardi, J Jayanthan, S Song, P Simpson, G Chenevix-Trench Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A85 (12 April 2012) |
|
Meeting abstract
Jonathan Beesley, Hilda Pickett, Sharon Johnatty, Xiaoqing Chen, Jun Li, David Rider, Michael Stutz, Diether Lambrecht, Jenny Chang-Claude, Thilo Dork, Marc Goodman, Bart Kiemmney, Elisa Bandera, Linda Kelemen, Shan Wang-Gorke, Ian Campbell, Simon Gayther, Susan Ramus, Ellen Goode, Roger Reddel, Georgia Chenevix-Trench, kConFab Investigators, Australian Ovarian Cancer Study Group Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A86 (12 April 2012) |
|
Meeting abstract
P Whiley, LC Walker, kConFab, M De LA Hoya, B Wappenschmidt, A Becker, A Blanco, MJ Blok, MA Caligo, C Chatfield, F Couch, O Diez, L Fachal, L Guidugli, S Enríquez, T Hansen, C Houdayer, S Imrie, A Lafferty, C Lázaro, M Menéndez, M Montagna, G Montalbán, M Santamariña, I Pederson, M Southey, M Tancredi, A Tenès, M Thomassen, A Van Overeem Vega, AB Spurdle, MA Brown et al. Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A87 (12 April 2012) |
|
Meeting abstract
BL Brewster, F Rossiello, JD French, SL Edwards, EM Wong, P Whiley, N Waddell, BreastCFR, kConFab, X Chen, B Bove, AB Spurdle, P Radice, AK Godwin, MC Southey, MA Brown, P Peterlongo Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A88 (12 April 2012) |
|
Meeting abstract
S Sawyer, S Boyle, MA Young, S Kovalenko, R Doherty, J McKinley, K Alsop, M Rehfisch, S Macaskill, A Ha, V Beshay, G Lindeman, M Harris, S Fox, G Mitchell, P James Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A89 (12 April 2012) |
|
Meeting abstract
Contribution of genetic variation within SuprMam1 and SuprMam2 to breast cancer susceptibility M Ratnadiwakara, M Rooke, R Williams, AC Blackburn Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A90 (12 April 2012) |
|
Meeting abstract
R Blanc, A Jammot, T Nguyen-Dumont, ZL Teo, FA Odefrey, F Hammet, VLSCI, BCFR, MCCS, DE Goldgar, DJ Park, MC Southey Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A91 (12 April 2012) |
|
Meeting abstract
ZL Teo, DJ Park, F Odefrey, F Hammet, T Nguyen-Dumont, H Tsimiklis, BJ Pope, A Lonie, I Winship, GG Giles, ABCFS, JL Hopper, MC Southey Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A92 (12 April 2012) |
|
Meeting abstract
C Johnson, KL Gorringe, ER Thompson, K Opeskin, SE Boyle, Y Wang, P Hill, GB Mann, IG Campbell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A93 (12 April 2012) |
|
Meeting abstract
The Australian Ovarian Cancer Study N Traficante, S Fereday, L Galletta, J Hung, D Giles, K Alsop, J Hendley, A Iuga, AOCS Study Group, G Chenevix-Trench, A Green, P Webb, A DeFazio, D Bowtell Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A94 (12 April 2012) |
|
Meeting abstract
The kConFab experience – 14 years of biobanking H Thorne, E Niedermayr, L Williams, A Willems-Jones, L Djandjgava, K Ioculano, C Osinski, kConFab research nurses, Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab) Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A95 (12 April 2012) |
